Inhibition of Urea Hydrolysis in Human Urine for Resource and Energy Recovery: Pharmaceuticals and Their Metabolites as Co-Existing Anticatalyzers

Abstract

Urine, which has a high concentration of urea, can be used as a sustainable resource for nutrient recovery and sustainable energy. However, urea undergoes hydrolysis, catalyzed by urease, generating ammonia and carbon dioxide. As ammonia is released during hydrolysis in stored urine, the pH rises progressively until the pKa of ammonium is reached (i.e., 9.3). At elevated pH levels, struvite and other related precipitates are formed. These reactions lower the efficiency of ammonia and urea nitrogen recovery and often cause scaling, pipe blockage, and odors. Herein, we explore an approach to stabilize urea, using pharmaceuticals and their metabolites that are commonly present in human urine. Based on a survey of the urease inhibitory effects of twenty-three pharmaceuticals and metabolites, we determined that the polyphenolic and disulfide-containing compounds had the highest urease inhibition efficiency. Specifically, outstanding inhibitors include catechol (CAT), hydroquinone (HYD), and disulfiram (DSF). Furthermore, when added to urine, these compounds resulted in the retardation of urease-catalyzed hydrolysis, leading to longer-term urine stabilization upon storage. Reaction mechanisms for urease inhibition by polyphenolics and disulfiram are proposed. Evidence is provided that pharmaceutical metabolites can stabilize urea and thus could lead to a sustainable method for nitrogen nutrient recovery from stored urine.